Don’t Count Pfizer Out In DMD

 
• By Jessica Merrill

Pfizer reminded investors it still has a gene therapy in Phase III development for Duchenne muscular dystrophy after Sarepta’s disappointing Phase III readout.

boxing ring
Pfizer is still in the fight against DMD • Source: Shutterstock

More from Gene Therapies

More from Advanced Therapies